Showing results (111-120 of 784) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|October 3, 2020
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a studyLindsey R Baden, Daniel J Stieh, Michal Sarnecki, et al.
The Lancet. HIV|October 3, 2020
Health systems software factors and their effect on the integration of sexual and reproductive health and HIV servicesSusannah H Mayhew, Charlotte E Warren, Charity Ndwiga, et al.
The Lancet. HIV|December 3, 2020
The case for an HIV cure and how to get thereMark Dybul, Timothy Attoye, Solange Baptiste, et al.
The Lancet. HIV|June 14, 2021
Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series studyDeborah Donnell, Ivana Beesham, Julia D Welch, et al.
The Lancet. HIV|October 31, 2020
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE studyMax Lataillade, Jacob P Lalezari, Michael Kozal, et al.
The Lancet. HIV|October 31, 2020
Global and regional epidemiology of HIV-1 recombinants in 1990-2015: a systematic review and global surveyJoris Hemelaar, Ramyiadarsini Elangovan, Jason Yun, et al.
The Lancet. HIV|July 1, 2022
Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, non-inferiority, implementation trialKenneth Ngure, Katrina F Ortblad, Peter Mogere, et al.
The Lancet. HIV|July 1, 2022
HIV incidence and impact of interventions among female sex workers and their clients in the Middle East and north Africa: a modelling studyHiam Chemaitelly, Houssein H Ayoub, Ryosuke Omori, et al.
The Lancet. HIV|December 4, 2020
The last Black man with HIV in San Francisco: the potential role of gentrification on HIV getting to zero achievementsJade Pagkas-Bather, Jonathan Ozik, Gregorio Millett, et al.
The Lancet. HIV|February 5, 2020
Novel metric for evaluating pre-exposure prophylaxis programme effectiveness in real-world settingsCheryl Hendrickson, Lawrence Long, David van de Vijver, et al.
Pageof 79